Unknown

Dataset Information

0

Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.


ABSTRACT: Alterations in central corticotropin-releasing factor signaling pathways have been implicated in the pathophysiology of anxiety disorders and irritable bowel syndrome (IBS). We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antagonist, GW876008, on brain and skin conductance responses during acquisition and extinction of conditioned fear to the threat of abdominal pain in subjects with IBS and healthy individuals (controls).We performed a single-center, randomized, double-blind, 3-period crossover study of 11 women with IBS (35.50 ± 12.48 years old) and 15 healthy women (controls) given a single oral dose (20 mg or 200 mg) of the CRF-R1 antagonist or placebo. Blood-oxygen level-dependent responses were analyzed using functional magnetic resonance imaging in a tertiary care setting.Controls had greater skin conductance responses during acquisition than extinction, validating the fear-conditioning paradigm. In contrast, during extinction, women with IBS had greater skin conductance responses than controls-an effect normalized by administration of a CRF-R1 antagonist. Although the antagonist significantly reduced activity in the thalamus in patients with IBS and controls during acquisition, the drug produced greater suppression of blood-oxygen level-dependent activity in a wide range of brain regions in IBS patients during extinction, including the medial prefrontal cortex, pons, hippocampus, and anterior insula.Although CRF signaling via CRF-R1 is involved in fear acquisition and extinction learning related to expected abdominal pain in patients with IBS and controls, this system appears to be up-regulated in patients with IBS. This up-regulation might contribute to the previously reported abnormal brain responses to expected abdominal pain.

SUBMITTER: Labus JS 

PROVIDER: S-EPMC4069031 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Labus Jennifer S JS   Hubbard Catherine S CS   Bueller Joshua J   Ebrat Bahar B   Tillisch Kirsten K   Chen Michelle M   Stains Jean J   Dukes George E GE   Kelleher Dennis L DL   Naliboff Bruce D BD   Fanselow Michael M   Mayer Emeran A EA  

Gastroenterology 20130814 6


<h4>Background & aims</h4>Alterations in central corticotropin-releasing factor signaling pathways have been implicated in the pathophysiology of anxiety disorders and irritable bowel syndrome (IBS). We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antagonist, GW876008, on brain and skin conductance responses during acquisition and extinction of conditioned fear to the threat of abdominal pain in subjects with IBS and healthy individuals (controls).<  ...[more]

Similar Datasets

| S-EPMC3434156 | biostudies-literature
| S-EPMC4726564 | biostudies-literature
| S-EPMC4755592 | biostudies-literature
| S-EPMC2697942 | biostudies-literature
| S-EPMC5622133 | biostudies-literature
| S-EPMC5048544 | biostudies-literature
| S-EPMC6406316 | biostudies-other
| S-EPMC3025045 | biostudies-literature
| S-EPMC4957789 | biostudies-literature
| S-EPMC5001845 | biostudies-literature